INBP.US Integrated Biopharma Inc

Consumer Defensive Personal Care Products USA Stocks
0.1700 USD
Close of Nov 4, 2026
0.1400 0.4200
Market cap
USD 5.28M
P/E
-
P/B
0.29x
ROE
-16.1%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the fiscal year ending Jun 2026.

Is INBP.US undervalued?

Graham number

The Graham number of Integrated Biopharma Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Integrated Biopharma Inc fundamental analysis

No fundamental analysis for Integrated Biopharma Inc yet.

Integrated Biopharma Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Integrated Biopharma Inc

Integrated BioPharma, Inc., together with its subsidiaries, engages in the manufacturing, distributing, marketing and sale of vitamins, nutritional supplements, and herbal products primarily in the United States and Luxembourg. The company operates through two segments, Contract Manufacturing and Other Business Lines. The Contract Manufacturing segment manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers, and specialized health-car…

Full company profile